-
Mashup Score: 4
bladder cancer, Non-Muscle Invasive Bladder Cancer (NMBIC), OncoTherad, Immunotherapy Associated with Platelet-Rich Plasma, high-risk non-muscular invasive bladder cancer (HRNMIBC), Toll-like Receptor (TLR), Toll-like Receptor agonists, tumor microenvironment, chemokine-mediated recruitment of specific immune cell types, BCG-unresponsive patient.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
high-grade non-muscle-invasive bladder cancer (HGNMIBC), non-muscle-invasive bladder cancer (NMIBC), NCT02324582, BCG therapy, post-BCG treatment, phase I dose-escalation trial.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3
high-grade non-muscle-invasive bladder cancer (HGNMIBC), non-muscle-invasive bladder cancer (NMIBC), NCT02324582, BCG therapy, post-BCG treatment, phase I dose-escalation trial.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3
high-grade non-muscle-invasive bladder cancer (HGNMIBC), non-muscle-invasive bladder cancer (NMIBC), NCT02324582, BCG therapy, post-BCG treatment, phase I dose-escalation trial.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
A novel therapeutic strategy for #NMIBC: OncoTherad® immunotherapy associated with platelet-rich plasma. #BeyondTheAbstract with Bianca Ribeiro de Souza, PhD @UBC on UroToday > https://t.co/C90Tm6CMR6 https://t.co/2LzXQuSODr